Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther H Zhou

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Asthma and Allergy|March 31, 2017
The US Food and Drug Administration's drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003-2012Esther H Zhou, Sally Seymour, Margie R Goulding, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database StudyJacqueline M Major, Esther H Zhou, Yulan Ding, et al.
Pharmacoepidemiology and Drug Safety|August 12, 2021
Trend changes of national zolpidem users and exposure cases after FDA drug safety communicationsEsther H Zhou, Zhou Feng, Ellen Pinnow, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 12, 2013
Antidepressant medication dispensing among montelukast initiatorsEsther H Zhou, Sigal Kaplan, Andrew Mosholder, et al.
Pharmacoepidemiology and Drug Safety|August 6, 2013
Concomitant use of isotretinoin and contraceptives before and after iPledge in the United StatesSimone P Pinheiro, Elizabeth M Kang, Clara Y Kim, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Journal of Health Communication|March 25, 2017
Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative AnalysisSteve Woloshin, Lisa M Schwartz, Sara Dejene, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|March 24, 2011
[A simplified Chinese version of the Quebec sleep questionnaire was evaluated for reliability and validity]Hong Huo, Wu-Yi Li, Jian-Han Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2010
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancerRodney J Ellis, Deborah A Kaminsky, Esther H Zhou, et al.
American Journal of Epidemiology|October 17, 2017
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort StudyAndrew D Mosholder, Joo-Yeon Lee, Esther H Zhou, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Asthma and Allergy|March 31, 2017
The US Food and Drug Administration's drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003-2012Esther H Zhou, Sally Seymour, Margie R Goulding, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database StudyJacqueline M Major, Esther H Zhou, Yulan Ding, et al.
Pharmacoepidemiology and Drug Safety|August 12, 2021
Trend changes of national zolpidem users and exposure cases after FDA drug safety communicationsEsther H Zhou, Zhou Feng, Ellen Pinnow, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 12, 2013
Antidepressant medication dispensing among montelukast initiatorsEsther H Zhou, Sigal Kaplan, Andrew Mosholder, et al.
Pharmacoepidemiology and Drug Safety|August 6, 2013
Concomitant use of isotretinoin and contraceptives before and after iPledge in the United StatesSimone P Pinheiro, Elizabeth M Kang, Clara Y Kim, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Journal of Health Communication|March 25, 2017
Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative AnalysisSteve Woloshin, Lisa M Schwartz, Sara Dejene, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|March 24, 2011
[A simplified Chinese version of the Quebec sleep questionnaire was evaluated for reliability and validity]Hong Huo, Wu-Yi Li, Jian-Han Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2010
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancerRodney J Ellis, Deborah A Kaminsky, Esther H Zhou, et al.
American Journal of Epidemiology|October 17, 2017
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort StudyAndrew D Mosholder, Joo-Yeon Lee, Esther H Zhou, et al.
Pageof 5